Premium Information is available for this item - Upgrade for $1 a day
3040-01-453-1067
Linear Actuating Cylinder Assembly
3040014531067 014531067 9SD-1
A cylinder containing a piston and other component parts designed to develop linear motion required to operate a given object(s) with energy generated from either pneumatic or hydraulic pressure(s). See also CYLINDER, ACTUATING, LINEAR. Do not use if a more specific name applies. View more Linear Actuating Cylinder Assembly
January 2023
1
Marketplace 3040-01-453-1067
Request a Quotation from participating marketplace vendors
Related Documents 3040-01-453-1067 1+ Documents (More...)
Cylinder Assembly 014531067 United States (US) 4. 3040-01-453-1067 Marketplace Restrictions Day 3040
-01-453-1067 RQST NE Restrictions 3040-01-453-1067 Restrictions 3040-01-453-1067 DEMIL: A | DEMILI :
Restrictions 3040-01-453-1067
3040-01-453-1067 is a Linear Actuating Cylinder Assembly that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item is not suspected to be hazardous. This item does not contain a precious metal.
End Users 3040-01-453-1067
- France (ZF01)
- Effective Date:
- 1 Feb 1998
Approved Sources 3040-01-453-1067
- Part Number
- Manufacturer
- Status
- 9SD-1
- Manufacturer
- 90526 - Clippard Instrument Laboratory Inc (Active)
- Primary Buy
- Primary Buy
Datasheet 3040-01-453-1067
- Characteristic
- Specifications
- FIIG
- Specifications
- A34200
- Design Characteristics [CKSD]
- Single Acting Single Cylinder
- Bore Diameter [ABXV]
- 0.562 Inches Nominal
Similar Supply Items to 3040-01-453-1067
Freight Information 3040-01-453-1067
3040-01-453-1067 has freight characteristics.. 3040-01-453-1067 has a variance between NMFC and UFC when transported by rail and the description should be consulted.